Psychedelics and cannabis: Regulatory risks, claims, and underwriting considerations
Casualty / Online seminar
properties.trackTitle
properties.trackSubtitle
October 22 - October 22 2024
Online seminar, 9.00 a.m. (CEST)
Save the Date
Duration: 60 minutes
General description
As the social acceptance and tolerance of psychedelics and cannabis continue to grow in many parts of the world, and for both medical and recreational use, corresponding regulatory, claims and underwriting risks are rapidly emerging. This session will explore how some of these drugs are being studied to treat mental illness and how the regulatory landscape is very much in flux, particularly in the US, where there are conflicts between state and federal laws.
Contents
- Offers a general understanding of psychedelics and cannabis
- Explores the legal aspects of psychedelics and cannabis
- Addresses Munich Re’s risk appetite for psychedelics and cannabis
Level
Target group
Middle management, Risk Management, ESG functions, general management responsibilities, Property and Casualty Underwriters
Language
English – professional business English skills required
Registration process
Our seminars are provided to our most valued clients only. If you are interested in participating, please get in touch with your client manager or responsible underwriter at Munich Re.
Date
22 October 2024
Deadline for registration
21 October 2024
